2021 annual financial data

ProQR Therapeutics 2021 Operating margin

Direct answer

Operating margin was -4,285.39%.

Operating income was -57.21M EUR and net income was -60.74M EUR.
Operating cash flow was -26.01M EUR.

Get free ProQR Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
1.34M EUR
Operating income
-57.21M EUR
Net income
-60.74M EUR
Operating cash flow
-26.01M EUR